Business Context and Reporting Period
Company: Chicago Atlantic BDC, Inc. (Ticker: LIEN)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2025
Business Overview: An externally managed Business Development Company (BDC) and Regulated Investment Company (RIC) focused on investing in the cannabis ecosystem and other complex, regulated industries. The company primarily invests in senior secured debt, unsecured debt, and equity warrants.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|
| Total Investment Income | $15.07 million | $40.07 million | $9.02 million |
| Net Investment Income | $9.49 million | $24.80 million | $1.46 million |
| Net Increase in Net Assets (Operations) | $8.83 million | $25.03 million | $1.65 million |
| Net Asset Value (NAV) per Share | $13.27 | $13.27 | $13.28 |
| Total Assets | $327.25 million | $327.25 million | $309.56 million (Dec 31, 2024) |
| Cash and Cash Equivalents | $10.46 million | $10.46 million | $23.93 million (Dec 31, 2024) |
| Revolving Line of Credit Outstanding | $11.00 million | $11.00 million | $0 |
| Portfolio Fair Value | $311.39 million | $311.39 million | $275.24 million (Dec 31, 2024) |
Material Changes vs. Prior Period
- Portfolio Expansion: The investment portfolio grew significantly from $275.2 million at year-end 2024 to $311.4 million at September 30, 2025. This growth is primarily attributed to the October 1, 2024, Loan Portfolio Acquisition, which added approximately $219.6 million in assets.
- Revenue Surge: Net investment income for the nine months ended September 30, 2025, increased to $24.8 million compared to $1.46 million in the same period in 2024, driven by the larger asset base.
- Expense Structure: Operating expenses increased to $17.3 million (YTD 2025) from $7.6 million (YTD 2024). This includes new interest expense ($0.79 million) and higher management/incentive fees due to asset growth. However, the company benefited from $1.34 million in expense waivers under the Expense Limitation Agreement.
- Liquidity: Cash and cash equivalents decreased from $23.9 million (Dec 31, 2024) to $10.5 million (Sep 30, 2025) due to investment purchases ($124.9 million) and distributions ($15.5 million), partially offset by $11.0 million in borrowings under a new revolving credit facility.
Guidance, Outlook, Risks, and Unusual Items
- Dividends: The company declared a quarterly dividend of $0.34 per share for the third quarter. On November 11, 2025, the Board approved a subsequent cash dividend of $0.34 per share payable January 15, 2026.
- Debt Facility: In February 2025, the company entered into a $100 million senior secured revolving credit agreement. As of September 30, 2025, $11 million was drawn with $89 million available.
- Key Risks:
- Cannabis Industry Concentration: 75.5% of the portfolio is invested in the cannabis industry, exposing the company to federal regulatory risks, banking restrictions, and industry-specific volatility.
- Valuation Uncertainty: 100% of the portfolio is classified as Level 3 assets (unobservable inputs), requiring significant management judgment for fair value determination.
- Interest Rate Risk: 69% of debt investments are floating-rate. Rising rates increase borrowing costs but also investment income; the net impact depends on the spread.
- Unusual Items: The filing notes a significant one-time transaction expense related to the Loan Portfolio Acquisition in the prior year ($5.07 million in 2024), which did not recur in 2025.
Investor Verification Checklist
- Portfolio Quality: Verify the credit risk ratings of the top three portfolio companies, which represent 34.2% of the total fair value.
- Dividend Coverage: Confirm that Net Investment Income ($24.8M YTD) sufficiently covers the declared distributions ($23.3M YTD) to ensure dividends are not a return of capital.
- Expense Cap: Review the terms of the Expense Limitation Agreement to understand the sustainability of the $1.34 million in expense waivers.
- Debt Covenants: Assess compliance with the new $100 million revolving credit facility covenants, particularly regarding asset coverage ratios.
- Regulatory Environment: Monitor changes in U.S. federal cannabis policy and their potential impact on the 75.5% of assets held in that sector.